Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hydrocortisone liquid - Eton Pharmaceuticals

Next Previous
Drug Profile

Hydrocortisone liquid - Eton Pharmaceuticals

Alternative Names: ET-400; ET-800; Hydrocortisone vial; KHINDIVI

Latest Information Update: 02 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Crossject
  • Developer Eton Pharmaceuticals
  • Class Alcohols; Anti-inflammatories; Antiallergics; Glucocorticoids; Pregnenediones; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Adrenal insufficiency
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Adrenal insufficiency

Most Recent Events

  • 20 Mar 2026 Eton Pharmaceuticals expects supplement new drug application (sNDA) approval for Hydrocortisone liquid in mid 2027
  • 20 Mar 2026 Eton Pharmaceuticals expects to file a supplement new drug application (sNDA) for Hydrocortisone liquid in the third quarter of 2026
  • 19 Mar 2026 Eton Pharmaceuticals initiates a bioequivalence study to support KHINDIVI label expansion beyond its current restriction to children aged five and older

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top